newsfilter

Rick Doblin

Showing 1–1 of 1 interviews.

  1. The Economist7 min

    How MDMA is being used to treat PTSD

    Rick Doblin, John Lubecki

    With standard treatments effective in only 20% of cases, researchers led by Rick Doblin are pursuing FDA approval for MDMA-assisted therapy after trials showed over 60% of participants no longer met PTSD criteria. The non-profit-funded study utilizes a regimen of three drug sessions paired with psychotherapy to allow veterans like John Lubecki to process trauma without fear, a potential breakthrough for the 8 million Americans suffering from the disorder. Because the drug cannot be patented, this initiative by a small organization aims to transform the illicit substance into a regulated medicine that addresses a public health crisis costing the Department of Veterans Affairs $400 million annually.